Anthem Blue Cross Connecticut Commercial Clinical Policy

Anthem Blue Cross Connecticut GENE.00057 Gene Expression Profiling for Idiopathic Pulmonary Fibrosis Form

Effective Date

06/28/2023

Last Reviewed

05/11/2023

Original Document

  Reference



This document addresses the use of gene expression profiling to assist in the diagnosis or management of idiopathic pulmonary fibrosis.

Note: Please see the following related document for additional information:

  • TRANS.00009 Lung and Lobar Transplantation

Position Statement

Investigational and Not Medically Necessary:

The use of gene expression profiling to assist in the diagnosis or management of idiopathic pulmonary fibrosis is considered investigational and not medically necessary in all situations.